Humana Inc Stock News

We believe that the healthcare stocks UnitedHealth (NYSE: UNH) and Humana HUM will likely see higher levels and offer similar returns in the next three years. Humana stock trades at 0.4x trailing reve

A government agency just approved a 3.7% payment rate increase for Medicare Advantage plans in 2025. That rate increase is risk-adjusted for the health of enrollees; the actual "core" payment rate wil

Humana's (HUM) partnership with CPESN USA in Ohio aims to overcome barriers like limited access to healthcare services in rural and underserved communities.

Humana, CVS, and UnitedHealth all fell after the CMS approved a 3.7% payment rate increase for Medicare Advantage plans for 2025. "Core" payments are actually expected to decline slightly after accoun

CNBC's Bertha Coombs reports on what's driving health insurer stocks lower.

Medicare Advantage payment rates for 2025 came in short of investor expectations.

The rate adds more pressure on insurers already grappling with high medical costs and uncertainty after the cyberattack on UnitedHealth Group's tech unit.

Higher costs and lower hikes in rates can lead to lower profit growth, which concerns investors.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Humana (HUM) led after-hours declines in healthcare stocks Monday evening, dropping nearly 10% after the Centers for Medicare & Medicaid Services (CMS) announced that federal payments to Medicare Adva

Humana (HUM) concluded the recent trading session at $351.45, signifying a +1.36% move from its prior day's close.

UnitedHealth, Humana and other big health insurers fell Monday night on lower-than-expected Medicare Advantage rates for 2025.

The market is near record highs and NVDA is up 11 straight weeks. Yet, blue-chip coiled spring bargains are still bountiful. VFLO is the best deep value strategy ETF I've found. A great combo of deep

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often

Humana (HUM) closed the most recent trading day at $347.09, moving -0.42% from the previous trading session.